1
Phase 2 Study of BA058 Transdermal Delivery in Postmenopausal Women With Osteoporosis
Condition(s): Post Menopausal Osteoporosis Last Updated: March 6, 2013Active, not recruiting
591 Clinical Trials for: Transdermal, Page 1 of 30
Hide Studies Not Seeking New Volunteers
2
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
Condition(s): Parkinson's Disease Last Updated: May 8, 2013Recruiting
3
Gabapentin Versus Transdermal Fentanyl Matrix for Chronic Neuropathic Pain
Condition(s): Neuropathic Pain; Spinal Stenosis Last Updated: July 19, 2011Enrolling by invitation
4
A Study to Assess the Relative Bioavailability of 4 Formulations of Fentanyl Transdermal System Compared Against DUROGESIC Fentanyl Transdermal Patch After Single Application in Healthy Volunteers
Condition(s): Healthy Last Updated: March 1, 2013Completed
5
Transdermal Basal Insulin Patch Study in Type 1 Diabetes
Condition(s): Type 1 Diabetes Last Updated: December 3, 2010Completed
6
Assessment of High Dose Transdermal Nicotine for Fast Metabolizers of Nicotine
Condition(s): Nicotine Dependence Last Updated: February 14, 2013Completed
7
The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers
Condition(s): Healthy Volunteers Last Updated: August 27, 2012Completed
8
Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day
Condition(s): Healthy Last Updated: March 31, 2008Completed
9
Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.
Condition(s): Osteoarthritis Last Updated: August 27, 2012Terminated
10
Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System
Condition(s): Healthy Last Updated: March 31, 2008Completed
11
Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr
Condition(s): Healthy Last Updated: March 31, 2008Terminated
12
Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System
Condition(s): Healthy Last Updated: March 31, 2008Completed
13
Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System With Askina Derm Overlay
Condition(s): Healthy Last Updated: March 31, 2008Completed
14
Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal System
Condition(s): Healthy Last Updated: March 31, 2008Completed
15
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain
Condition(s): Chronic Non-malignant Pain Last Updated: September 5, 2012Completed
16
Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms
Condition(s): Hot Flashes Last Updated: June 8, 2012Completed
17
Transdermal Fentanyl Patch for Postoperative Analgesia After Abdominal Surgery: a Randomized Placebo-controlled Trial
Condition(s): Postoperative Pain Relief Last Updated: November 14, 2012Completed
18
A Relative Bioavailability Study of Fentanyl 25 μg/h Transdermal System
Condition(s): Healthy Last Updated: August 13, 2010Completed
19
Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee
Condition(s): Osteoarthritis Last Updated: August 27, 2012Completed
20
Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy
Condition(s): Breast Cancer; Nausea; Vomiting Last Updated: March 13, 2013Recruiting
